Kebuzone: Difference between revisions

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

Revision as of 00:27, 1 July 2011 edit CheMoBot (talk \| contribs) Bots 141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject_Ph ← Previous edit		Latest revision as of 00:18, 27 October 2023 edit undo Kimen8 (talk \| contribs) Extended confirmed users 4,866 edits Changing short description from "Chemical compound" to "NSAID anti-inflammatory medication" Tag: Shortdesc helper
(32 intermediate revisions by 21 users not shown)
Line 1: {{Short description\|NSAID anti-inflammatory medication}} ~~{{drugbox~~ {{Drugbox \| Verifiedfields = changed \| ~~UNII_Ref~~Watchedfields = ~~{{fdacite\|~~changed~~\|FDA}}~~ \| verifiedrevid = ~~407571001~~447986588▼ \| IUPAC_name = 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione▼ \| image = ~~kebuzone~~Kebuzone.png▼ <!--Clinical data--> \| tradename = \| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->▼ \| pregnancy_US = <!-- A / B / C / D / X -->▼ \| pregnancy_category= = ▼ \| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->▼ \| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->▼ \| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->▼ \| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->▼ \| legal_status = ▼ \| routes_of_administration = [[intramuscular]]▼ <!--Pharmacokinetic data--> \| bioavailability = ▼ \| protein_bound = ▼ \| metabolism = \| elimination_half-life = 70–100 hours▼ \| excretion = [[renal]]▼ <!--Identifiers--> \| CAS_number_Ref = {{cascite\|correct\|??}} \| CAS_number = 853-34-9▼ \| ATC_prefix = M01▼ \| ATC_suffix = AA06 ▼ \| PubChem = 3824▼ \| ChemSpiderID_Ref = {{chemspidercite\|changed\|chemspider}} \| ChemSpiderID = 3692 \| DrugBank_Ref = {{drugbankcite\|changed\|drugbank}} \| DrugBank = =DB08940 ▼ \| UNII_Ref = {{fdacite\|correct\|FDA}} \| UNII = 4VD83UL6Y6 ▲\| verifiedrevid = 407571001 ▲\| IUPAC_name = 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione ▲\| image = kebuzone.png ▲\| CAS_number = 853-34-9 ▲\| ATC_prefix = M01 ▲\| ATC_suffix = AA06 ▲\| PubChem = 3824 ▲\| DrugBank = \| KEGG_Ref = {{keggcite\|correct\|kegg}} \| KEGG = D01567 \| ChEBI_Ref = {{ebicite\|changed\|EBI}} ~~\| C=19\|H=18\|N=2\|O=3~~ \| ChEBI = 31749 ~~\| molecular_weight = 322.35782 g/mol~~ ▲\| bioavailability = <!--Chemical data--> ▲\| protein_bound = \| ~~metabolism~~ C=19 \| H=18 \| N=2 \| O=3 \| smiles = CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 ▲\| elimination_half-life = \| StdInChI_Ref = {{stdinchicite\|changed\|chemspider}} ▲\| excretion = \| StdInChI = 1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3 ▲\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> \| StdInChIKey_Ref = {{stdinchicite\|changed\|chemspider}} ▲\| pregnancy_US = <!-- A / B / C / D / X --> \| StdInChIKey = LGYTZKPVOAIUKX-UHFFFAOYSA-N ▲\| pregnancy_category= ▲\| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> ▲\| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> ▲\| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> ▲\| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> ▲\| legal_status = ▲\| routes_of_administration = }} '''Kebuzone''' (or '''ketophenylbutazone''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID) that is used for the treatment of inflammatory conditions such as [[thrombophlebitis]] and [[rheumatoid arthritis]] (RA).<ref name="AustriaCodex">{{cite book\|title=Austria-Codex\|at=Rheumesser 3 ml-Ampullen\|publisher=Österreichischer Apothekerverlag\|location=Vienna\|year=2018\|language=German}}</ref><ref>{{Cite web\|url=https://drugs.ncats.io/drug/4VD83UL6Y6\| work = NCATS Inxight: Drugs \| title = KEBUZONE \|language=en\|access-date=2019-02-27}}</ref><ref>{{cite book \| vauthors = Aronson JK \| chapter = Kebuzone \|title=Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions \|date=2016 \|location=Amsterdam \|isbn=978-0-444-53716-4 \|page=405 \|edition=Sixteenth \| chapter-url=https://books.google.com/books?id=NOKoBAAAQBAJ&dq=Kebuzone&pg=RA3-PA405}}</ref> ~~'''Kebuzone''' (or '''ketophenylbutazone''') is a [[non-steroidal anti-inflammatory drug]].~~ ==References== {{Reflist}} {{Anti-inflammatory and antirheumatic products}} ~~{{NSAIDs}}~~ [[Category:Ketones]] [[Category:Pyrazolidindiones]] [[Category:Nonsteroidal anti-inflammatory drugs]]